Tools4Patient's R&D is focused on the continued development and optimization of technologies to empower the pharma, biotech and medical device industries.

 Collaborations to Apply Emerging Technologies 

Tools4Patient is developing tools to address key sources of data variability throughout the clinical trial value chain. These technologies aim to improve the conduct of trials and analysis of data by mathematically characterizing innate patient characteristics – including personality, emotional status and social support – that impact variable response to treatment.

As part of our commitment to R&D and to the Biopharma community, Tools4Patient is making early-stage technologies available to companies, in partnership, under an open innovation model. These collaborations are highly scientific and intended to allow innovative companies early access to these emerging technologies.

Reduce data variability related to the placebo response across indications and therapeutic areas

Expansion of the Placebell©™ Platform
Tools4Patient is currently validating Placebell©™ in areas including pain, neurology, psychiatry, ophthalmology and beyond. Tools4Patient is seeking partners to collaboratively validate Placebell©™ in other indications in which the placebo response compromises efficacy demonstration. Placebell©™ is easily implemented and comes with no risk of compromising data analysis of any trial.


Tools4Patient Pipeline 2020

Partnership Opportunities


Tools4Patient is seeking collaboration to apply the COV-IQ methodology in clinical trials being conducting during the COVID-19 pandemic – or any crisis situation. This approach could be applied to current or future pandemics, during personal health crisis, or other crisis situations at the global, local or personal level.